AstraZeneca shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in AstraZeneca
Tip: Access up to 7 years of quarterly data
All positions including AstraZeneca held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in AstraZeneca by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $4.9B | 63M | 77.91 |
| 2024-06-30 | $5.1B | 65M | 77.99 |
| 2024-03-31 | $4.2B | 61M | 67.75 |
| 2023-12-31 | $3.5B | 52M | 67.35 |
| 2023-09-30 | $3.6B | 54M | 67.72 |
| 2023-06-30 | $3.8B | 53M | 71.57 |
| 2023-03-31 | $4.1B | 59M | 69.41 |
| 2022-12-31 | $4.7B | 69M | 67.80 |
| 2022-03-31 | $6.3B | 94M | 66.34 |
| 2021-12-31 | $5.2B | 90M | 58.25 |
| 2021-09-30 | $4.9B | 82M | 60.06 |
| 2021-06-30 | $4.1B | 68M | 59.90 |
| 2021-03-31 | $2.9B | 58M | 49.72 |
| 2020-12-31 | $930M | 19M | 49.99 |
| 2020-09-30 | $858M | 16M | 54.80 |
| 2020-06-30 | $720M | 14M | 52.89 |
| 2020-03-31 | $562M | 13M | 44.66 |
| 2019-12-31 | $600M | 12M | 49.86 |
| 2019-09-30 | $546M | 12M | 44.57 |
| 2019-06-30 | $525M | 13M | 41.28 |
| 2019-03-31 | $454M | 11M | 40.43 |
| 2018-12-31 | $522M | 14M | 37.98 |
| 2018-09-30 | $522M | 13M | 39.57 |
| 2018-06-30 | $476M | 14M | 35.11 |
| 2018-03-31 | $527M | 15M | 34.97 |
| 2017-12-31 | $507M | 15M | 34.70 |
| 2017-06-30 | $422M | 12M | 34.09 |
| 2017-03-31 | $379M | 12M | 31.14 |
| 2016-12-31 | $287M | 11M | 27.32 |
| 2016-09-30 | $42M | 1.3M | 32.86 |
| 2014-03-31 | $95M | 1.5M | 64.88 |
| 2013-12-31 | $113M | 1.9M | 59.37 |
| 2013-09-30 | $91M | 1.8M | 51.93 |
| 2013-06-30 | $75M | 1.6M | 47.30 |